ENDRA Life Sciences (NDRA) director Tokman received 109,323 Stock Options
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Alexander Y Tokman (director at ENDRA Life Sciences Inc., NDRA) reported that they received 109,323 Stock Options on Mar 28, 2022.
- Reporting person
- Tokman Alexander Y
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 28, 2022 | Grant or award (A) | Stock OptionsOn 109,323 Common Stock1 | +109,323 | - | - | 109,323 direct |
Holdings before and after
- Stock Options: 0 to 109,323 direct
Footnotes from the filing
- 1. This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Tokman report in this NDRA Form 4?
Alexander Y Tokman (director at ENDRA Life Sciences Inc., NDRA) reported that they received 109,323 Stock Options on Mar 28, 2022.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for NDRA
Earlier insider filings at NDRA
- Mar 30, 2022SEC Form 4 filed by Pestrikova Irina
- Mar 30, 2022SEC Form 4 filed by Harsh Michael
- Mar 30, 2022SEC Form 4 filed by Michelon Francois Roger
- Mar 30, 2022SEC Form 4 filed by Basenese Lou
- Jan 4, 2022SEC Form 4 filed by Tokman Alexander Y
Quantisnow market dataNASDAQ
NDRA
ENDRA Life Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2017
Get push alerts for NDRA
Full NDRA profile on Quantisnow Follow NDRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time